Asbestos Mesothelioma – Gendicine, Could It Be the Next Promising Cure For Cancer?

Europe and the United States are probably still a year away from the licensing of gene therapy, however, there are currently at least two clinical trials testing gene therapy for mesothelioma. They include the University of Pennsylvania and Louisiana State University. Unfortunately, gene therapy research is a major blow in 1999 when teenager Jesse Gelsinger died during a gene therapy clinical trial at the University of Pennsylvania.

Nevertheless, China is now the only country in the world which is already approved gene therapy. 16th October 2003, a drug called Gendicine was approved by the State Food and Drug Administration of China. Gendicine had more than 5 years of clinical testing before being approved. They currently have the benefit of this therapy to more than 4500 patients and followed their patient's progress for more than six years. Now, hundreds of cancer patients from around the world travel to Beijing to receive this leading edge treatment.

A clinical trial included 135 patients Gendicine and the results showed that 64% of patients showed tumor after 8 weekly injections in combination with radiation. According to the results of clinical trials, using Gendicine with chemotherapy and radiation therapy can improve the efficiency of 3 puta.Samo Gendicine is a typical side effects overnight fever.